Susquehanna International Group, LLP Infinity Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	BUY	$0.14 - $0.24 $14 - $24	100 Added 0.28%	36,000 $7,000
Q1 2023 May 16, 2023	SELL	$0.16 - $0.74 $8,496 - $39,294	-53,100 Reduced 59.66%	35,900 $5,000
Q4 2022 Feb 14, 2023	SELL	$0.46 - $1.21 $34,730 - $91,355	-75,500 Reduced 45.9%	89,000 $49,000
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.7 $23,541 - $67,830	39,900 Added 32.02%	164,500 $196,000
Q2 2022 Aug 15, 2022	BUY	$0.49 - $1.2 $539 - $1,320	1,100 Added 0.89%	124,600 $78,000
Q1 2022 May 16, 2022	SELL	$0.85 - $2.4 $222,360 - $627,840	-261,600 Reduced 67.93%	123,500 $141,000
Q4 2021 Feb 14, 2022	SELL	$1.86 - $3.36 $295,926 - $534,576	-159,100 Reduced 29.24%	385,100 $866,000
Q3 2021 Nov 15, 2021	BUY	$1.52 - $3.82 $607,544 - $1.53 Million	399,700 Added 276.61%	544,200 $1.86 Million
Q2 2021 Aug 11, 2021	BUY	$2.66 - $3.47 $141,778 - $184,951	53,300 Added 58.44%	144,500 $432,000
Q1 2021 May 17, 2021	BUY	$1.98 - $5.36 $95,436 - $258,352	48,200 Added 112.09%	91,200 $295,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $2.77 $21,630 - $57,062	20,600 Added 91.96%	43,000 $91,000
Q3 2019 Nov 14, 2019	BUY	$1.03 - $1.75 $2,266 - $3,850	2,200 Added 10.89%	22,400 $23,000
Q2 2019 Aug 14, 2019	SELL	$1.43 - $1.87 $2,288 - $2,992	-1,600 Reduced 7.34%	20,200 $36,000
Q1 2019 May 15, 2019	SELL	$1.18 - $1.91 $93,692 - $151,654	-79,400 Reduced 78.46%	21,800 $41,000
Q4 2018 Feb 14, 2019	SELL	$1.01 - $2.78 $43,834 - $120,651	-43,400 Reduced 30.01%	101,200 $119,000
Q3 2018 Nov 14, 2018	BUY	$1.72 - $2.71 $34,572 - $54,471	20,100 Added 16.14%	144,600 $392,000
Q2 2018 Aug 14, 2018	BUY	$1.72 - $2.26 $174,924 - $229,841	101,700 Added 446.05%	124,500 $238,000
Q1 2018 May 15, 2018	BUY	$1.8 - $2.74 $41,040 - $62,472	22,800 New	22,800 $48,000

Others Institutions Holding INFI

# of Institutions

Shares Held

1.26M

Call Options Held

Put Options Held

View Full List

About INFINITY PHARMACEUTICALS, INC.

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

More about INFI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account